Xenon Pharmaceuticals Inc (NASDAQ:XENE)

15.84
Delayed Data
As of Sep 21
 -0.48 / -2.95%
Today’s Change
9.32
Today|||52-Week Range
21.94
+2.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$713.7M

Company Description

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Contact Information

Xenon Pharmaceuticals, Inc.
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
P:(604) 484-3300
Investor Relations:
(604) 484-3353

Employees

Shareholders

Other institutional52.31%
Mutual fund holders29.63%
Individual stakeholders14.71%

Top Executives

Ian C. MortimerPresident, Chief Executive Officer & Director
Sherry AulinChief Financial Officer
Sheila M. GrantSenior VP-Research & Development Operations
Christopher KenneyChief Medical Officer
Robin SherringtonExecutive Vice President-Strategy & Innovation